Market Overview

24 Stocks Moving In Wednesday's Pre-Market Session

Share:

Gainers

  • Command Security Corporation (NYSE: MOC) rose 42.1 percent to $2.70 in pre-market trading after the company agreed to be acquired by Prosegur for $2.85 per share.
  • Tilray, Inc. (NASDAQ: TLRY) shares rose 35.5 percent to $210.00 in pre-market trading after climbing 28.95 percent on Tuesday.
  • New Age Beverages Corporation (NASDAQ: NBEV) shares rose 16.7 percent to $3.29 in pre-market trading after surging 22.61 percent on Tuesday.
  • Pyxus International, Inc. (NYSE: PYX) rose 13.1 percent to $24.15 in pre-market trading after climbing 16.99 percent on Tuesday.
  • Cronos Group Inc. (NASDAQ: CRON) rose 9.2 percent to $12.62 in pre-market trading after surging 13.56 percent on Tuesday.
  • Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT) rose 7.7 percent to $4.60 in pre-market trading. Neptune confirmed its name change to Neptune Wellness Solutions.
  • Canopy Growth Corporation (NYSE: CGC) rose 7.5 percent to $55.80 in pre-market trading after gaining 6.77 percent on Tuesday.
  • 3Pea International, Inc. (NASDAQ: TPNL) rose 7.1 percent to $5.30 in pre-market trading after surging 8.08 percent on Tuesday.
  • Mechel PAO (NYSE: MTL) shares rose 6.5 percent to $2.77 in pre-market trading after gaining 3.54 percent on Tuesday. Citigroup upgraded Mechel from Sell to Neutral.
  • Inovio Pharmaceuticals, Inc. (NASDAQ: INO) rose 5.8 percent to $5.15 in pre-market trading.
  • Stein Mart, Inc. (NASDAQ: SMRT) shares rose 5.6 percent to $2.08 in pre-market after the company reported a five-year extended and amended $275 million credit agreement.
  • Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 5.4 percent to $20.50 in pre-market trading after climbing 87.30 percent on Tuesday.
  • SunPower Corporation (NASDAQ: SPWR) rose 5.2 percent to $7.94 in pre-market trading after climbing 14.74 percent on Tuesday. Credit Suisse upgraded SunPower from Neutral to Outperform and raises the price target from $8 to $10.
  • CEL-SCI Corporation (NYSE: CEL) rose 5 percent to $4.00 in pre-market trading after declining 1.30 percent on Tuesday.
  • Medpace Holdings, Inc. (NASDAQ: MEDP) rose 4.7 percent to $66.73 in pre-market trading after gaining 2.07 percent on Tuesday.

 

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • IZEA Worldwide Inc (NASDAQ: IZEA) fell 7.1 percent to $1.59 in pre-market trading. IZEA priced its 1.407 million shares at $1.50 per share for gross proceeds of $2.111 million.
  • Platform Specialty Products Corp (NYSE: PAH) shares fell 4.3 percent to $12.25 in pre-market trading. Citigroup downgraded Platform Specialty from Buy to Neutral.
  • Hertz Global Holdings, Inc. (NYSE: HTZ) fell 4.3 percent to $18.18 in pre-market trading after rising 1.82 percent on Tuesday.
  • Nokia Corporation (NYSE: NOK) fell 4 percent to $5.40 in pre-market trading. Credit Suisse upgraded Nokia from Neutral to Outperform.
  • EVO Payments Inc (NASDAQ: EVOP) fell 3.8 percent to $25.25 in pre-market trading after reporting an offering of 6.022 million shares.
  • G1 Therapeutics, Inc. (NASDAQ: GTHX) fell 3.3 percent to $60.85 in pre-market trading after dropping 5.21 percent on Tuesday.
  • Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) shares fell 2.7 percent to $4.39 in pre-market trading after declining 1.10 percent on Tuesday.
  • Brookfield Renewable Partners L.P. (NYSE: BEP) shares fell 2.4 percent to $30.74 in pre-market after announcing plans to issue CDN$300 million green bond.
  • LyondellBasell Industries N.V. (NYSE: LYB) shares fell 2.2 percent to $99.90 in pre-market trading. JP Morgan downgraded LyondellBasell from Neutral to Underweight.

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas

 

Related Articles (CEL + BEP)

View Comments and Join the Discussion!

The Daily Biotech Pulse: Johnson & Johnson's Generic Unit Files NDA For Urinary Tract Cancer Drug, G1 Therapeutics Prices Offering

A Peek Into The Markets: US Stock Futures Flat Ahead Of Housing Starts, Current Account Data